Recently, studies in mouse models and in women, report an obesity-inflammation-aromatase axis associated with NF-κB activation, elevated levels of pro-inflammatory mediators and increased aromatase expression. Here, CYP19A1 is linked to obesity due to melanocortin 4 receptor deficiency.